Top

Published in:

01-01-2009 | Invited Commentary

To Measure the Unmeasurable

Author: Michael Gnant

Published in: World Journal of Surgery | Issue 1/2009

Excerpt

In their article Takahido Shien and colleagues from the National Cancer Center Hospital in Tokyo, report their experiences with using clinical and pathological tumor features as predictors of the response of breast tumors to neoadjuvant chemotherapy [1]. …

Shien T, Akashi-Tanaka S, Miyakawa K (2008) Clinicopathological and imaging classification of tumors as predictors of the efficacy of neoadjuvant chemotherapy for operable breast cancer. World J Surg. doi:10.1007/s00268-008-9800-9 [Epub ahead of print]

Wenzel C, Bartsch R, Hussian D et al (2007) Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF. Breast Cancer Res Treat 104:109–114PubMedCrossRef

Buzdar AU (2007) Preoperative chemotherapy treatment of breast cancer—a review. Cancer 110:2394–2407PubMedCrossRef

Mieog JS, van der Hage JA, van de Velde CJ (2007) Neoadjuvant chemotherapy for operable breast cancer. Br J Surg 94:1189–1192PubMedCrossRef

Schegerin M, Tosteson AN, Kaufman PA et al. (2008) Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective. Breast Cancer Res Treat. 25 April [Epub ahead of print]

Esteva FJ, Hortobagyi GN (2008) Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer? J Natl Cancer Inst 100:521–523PubMedCrossRef

Marcus CD, Ladam-Marcus V, Cucu C, et al. (2008) Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol. 28 August [Epub ahead of print]

Soucy G, Bélanger J, Leblanc G et al (2008) Surgical margins in breast-conservation operations for invasive carcinoma: does neoadjuvant chemotherapy have an impact? J Am Coll Surg 206:1116–1121PubMedCrossRef

Goldstein NS, Decker D, Severson D et al (2007) Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer 110:1687–1696PubMedCrossRef

Title: To Measure the Unmeasurable
Author: Michael Gnant
Publication date: 01-01-2009
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 1/2009
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-008-9801-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

To Measure the Unmeasurable

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2009

Preventing Parastomal Hernia with a Prosthetic Mesh: A 5-Year Follow-up of a Randomized Study

Population Health Metrics for Surgery: Effective Coverage of Surgical Services in Low-Income and Middle-Income Countries

Prognostic Factors After Resection of Pancreatic Cancer

Esophagus and Gastric Cancer: How Surgeon’s Experience and Personal Genomics May Improve Locoregional Control and Survival

Alternative Surgical Strategies and Favorable Outcomes in Patients with Medullary Thyroid Carcinoma in Japan: Experience of a Single Institution

Prevalence of Symptoms and Use of Medication for Gastroesophageal Reflux in an Australian Community